Back to search

University of Edinburgh

Dynamics of myelin swelling during early demyelination

Abstract

dc:description.abstract

Myelin is a lipid-rich insulating sheath that surrounds axons and is produced by oligodendrocytes in the central nervous system (CNS). Myelin loss is a major pathological feature of multiple sclerosis (MS) and also occurs in many other neurological conditions. Although the consequences of demyelination and the mechanisms of remyelination have been extensively studied, the early structural changes preceding complete myelin loss remain less well understood. Recent work from the Lyons laboratory has shown that, during early myelin damage, myelin sheaths can form swellings, and that these myelin swellings do not always lead to subsequent demyelination or oligodendrocyte degeneration. Indeed, live imaging in zebrafish models of demyelination has demonstrated that myelin swellings can sometimes resolve, allowing the myelin sheaths to return to their original morphology. This raises the possibility that myelin swelling represents a dynamic and potentially reversible stage of early myelin damage. This thesis investigates the dynamics, pathological relevance and mechanisms of myelin swelling during early myelin damage. First, I examined post-mortem human MS brain tissue to assess whether myelin swelling is associated with active lesions, which are thought to reflect ongoing demyelinating pathology. Myelin swellings were more prevalent around active and chronic active lesions, suggesting that swelling is a feature of ongoing myelin damage in human disease and may occur prior to complete myelin loss. I then used zebrafish models of demyelination to investigate myelin swelling in vivo using longitudinal live imaging of individual myelin sheaths and oligodendrocytes. I pharmacologically manipulated neuronal activity by targeting voltage-gated sodium channels and found that this altered the extent of myelin swelling and damage, with increased activity exacerbating swelling and reduced activity mitigating swelling. Longitudinal cell tracking further showed that oligodendrocytes with a greater burden of acute myelin swelling were more likely to subsequently degenerate, linking the severity of early myelin pathology to longer-term cellular outcomes. Therefore, I found that reducing myelin swelling was associated with enhanced oligodendrocyte survival, suggesting that manipulating this early stage of damage may influence subsequent cell fate. However, reduced myelin swelling was not sustained following treatment withdrawal, suggesting that reducing neuronal activity may temporarily alleviate, rather than eliminate, the processes driving myelin damage. Nonetheless, the association between reduced swelling and enhanced oligodendrocyte survival supports the possibility that early myelin damage represents a stage at which interventions could promote oligodendrocyte survival and limit subsequent myelin loss. Finally, I investigated candidate mechanisms that may contribute to the formation and resolution of myelin swelling. I began by investigating the composition of myelin swellings and whether they formed intracellularly or in extracellular spaces between myelin lamellae. Some swellings were clearly intracellular, whereas for larger swellings it was not possible to determine whether the swelling itself was intracellular or extracellular, despite the presence of intracellular components within them. These observations suggest that myelin swellings may be structurally heterogeneous, although whether these differences relate to swelling size, location within the myelin ultrastructure, or the underlying mechanism of formation remains unclear. Additionally, calcium ions were detected in myelin swellings, suggesting that altered calcium homeostasis may play a role in early myelin damage. I then explored other pharmacological manipulations of potassium ion channel activity to further understand whether they contribute to myelin swelling. Blocking voltage-gated potassium channels exacerbated swelling, providing further evidence that altered neuronal excitability and ion movement can influence the severity of this pathology. Together, these findings support the hypothesis that disrupted ionic and osmotic homeostasis contributes to swelling dynamics, although the specific channels involved remain unresolved. This thesis demonstrates that myelin swelling is a dynamic and modifiable feature of early myelin damage that is present in human MS tissue and experimental models. I found that the severity of acute myelin swelling can be modulated at the cellular level by targeting voltage-gated sodium channels, and that this modulation is associated with subsequent oligodendrocyte fate. Additionally, the ability of myelin to resolve swellings suggests that early myelin damage does not inevitably progress to demyelination. These findings highlight the importance of determining the mechanisms underlying myelin swelling and identifying the downstream processes through which neuronal activity influences myelin damage. Ultimately, myelin swelling may represent an early window during which these processes could be targeted to promote oligodendrocyte survival and prevent subsequent myelin loss in demyelinating disease.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • van de Korput, Julia
Advisors dc:contributor.advisor
  • Williams, Anna
  • Lyons, David
  • Hunt, David

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

van de Korput, Julia. Dynamics of myelin swelling during early demyelination. 2026. https://hdl.handle.net/1842/45526